Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taiwan - Delayed Quote TWD

Maxigen Biotech Inc. (1783.TW)

41.90
-1.85
(-4.23%)
At close: 1:30:35 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
730.77M
680.65M
622.12M
604.43M
511.98M
Cost of Revenue
209.96M
197.33M
198.02M
230.44M
250.95M
Gross Profit
520.82M
483.32M
424.09M
373.99M
261.03M
Operating Expense
312.72M
288.95M
274.05M
240.66M
168.06M
Operating Income
208.09M
194.38M
150.05M
133.33M
92.97M
Net Non Operating Interest Income Expense
8.98M
9.71M
12.31M
3.11M
285.00k
Pretax Income
246.09M
225.54M
193.14M
165.78M
97.47M
Tax Provision
37.25M
35.38M
27.31M
26.38M
9.80M
Net Income Common Stockholders
208.84M
190.17M
165.83M
139.40M
87.67M
Diluted NI Available to Com Stockholders
208.84M
190.17M
165.83M
139.40M
87.67M
Basic EPS
2.34
2.13
1.86
1.57
1.04
Diluted EPS
2.32
2.12
1.85
1.56
1.04
Basic Average Shares
89.11M
89.10M
88.93M
88.93M
84.23M
Diluted Average Shares
90.13M
89.70M
89.45M
89.39M
84.51M
Total Expenses
522.68M
486.27M
472.07M
471.10M
419.00M
Net Income from Continuing & Discontinued Operation
208.84M
190.17M
165.83M
139.40M
87.67M
Normalized Income
210.11M
202.37M
166.00M
143.37M
90.39M
Interest Income
8.98M
9.71M
12.31M
3.18M
481.00k
Interest Expense
--
--
0.00
68.00k
196.00k
Net Interest Income
8.98M
9.71M
12.31M
3.11M
285.00k
EBIT
208.09M
194.38M
150.05M
165.85M
97.66M
EBITDA
235.72M
221.40M
177.66M
195.43M
130.56M
Reconciled Cost of Revenue
209.96M
197.33M
198.02M
230.44M
250.95M
Reconciled Depreciation
27.62M
27.02M
27.62M
29.58M
32.90M
Net Income from Continuing Operation Net Minority Interest
208.84M
190.17M
165.83M
139.40M
87.67M
Total Unusual Items Excluding Goodwill
-1.50M
-14.47M
-199.00k
-4.72M
-3.02M
Total Unusual Items
-1.50M
-14.47M
-199.00k
-4.72M
-3.02M
Normalized EBITDA
237.21M
235.87M
177.86M
200.15M
133.59M
Tax Rate for Calcs
0.15
0.16
0.14
0.16
0.10
Tax Effect of Unusual Items
-226.43k
-2.27M
-28.14k
-750.33k
-304.03k
12/31/2021 - 10/3/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.